MGF
Mechano Growth Factor (MGF) is a locally-acting splice variant of IGF-1 (IGF-1Ec) studied for its proposed role in activating muscle stem cells and triggering early muscle repair after mechanical loading. Evidence is almost entirely animal and cell-culture based, with no human therapeutic trials.
In plain English
MGF is a short-lived form of the muscle growth signal IGF-1 that the body makes inside muscle right after it is damaged by exercise. In lab dishes and animals, a synthetic piece of this molecule appears to wake up muscle stem cells so they can repair and rebuild fibers. The catch: the human evidence for injecting MGF as a peptide simply does not exist yet, some careful lab studies found no effect at all, and it is banned in sport. Treat it as an experimental research compound, not a proven therapy.
What it is
MGF (Mechano Growth Factor) is the name given to a splice variant of insulin-like growth factor 1 (IGF-1), known in humans as IGF-1Ec. When muscle is mechanically loaded or injured, the IGF-1 gene can be spliced to produce this variant, whose distinctive feature is a C-terminal 'E domain' peptide. Research peptides sold as 'MGF' or 'PEG-MGF' are synthetic versions of that ~24-amino-acid C-terminal E-peptide (PEG-MGF adds a polyethylene glycol group intended to extend its very short half-life). It is a research chemical, not an approved drug.
Mechanism (summary)
The proposed mechanism is that MGF acts as an early, autocrine/paracrine 'first responder' after muscle damage. Animal and cell-culture work suggests the MGF E-peptide activates quiescent satellite cells (muscle stem cells), promotes their proliferation, and delays terminal differentiation, increasing the pool of cells available to repair and fuse with damaged fibers. Notably, the E-peptide's effects appear to be independent of the classic IGF-1 receptor, implying a separate, still poorly characterized receptor or pathway. This model is debated: some researchers question whether the predicted MGF peptide is actually produced in vivo at meaningful levels, and at least one careful in vitro study found no effect of the synthetic peptide on myoblasts or muscle stem cells.
Why people research it
- Whether the MGF E-peptide can activate satellite (muscle stem) cells to accelerate muscle repair after damage
- Its potential role in counteracting age-related muscle loss (sarcopenia) by restoring stem-cell responsiveness
- As a tool for understanding how mechanical loading is translated into local muscle growth signals (mechanotransduction)
- Possible regenerative applications beyond skeletal muscle, including cardiac and neural tissue in animal models
Human evidence
There are no published human randomized controlled trials of MGF as a therapeutic peptide, and it is not approved for human use anywhere. The closest human-relevant data come from cell-culture experiments using human muscle progenitor cells, where the MGF E-peptide enhanced activation and fusion potential in samples from younger donors. These are in vitro findings on isolated cells, not clinical outcomes in living people, and they cannot establish safety, dosing, or real-world efficacy. Any claims of human muscle-building or recovery benefits from injectable MGF are unsupported by controlled clinical evidence.
Animal / lab evidence
Most of the supporting evidence is from rodents and cell culture. In rat skeletal muscle, the IGF-1 gene is rapidly spliced toward the MGF variant after local damage, and this early MGF 'pulse' is associated with satellite-cell activation, preceding the later rise in the systemic IGF-1Ea variant linked to protein synthesis. In vitro, the synthetic MGF E-peptide has been reported to increase myoblast proliferation while inhibiting premature differentiation in some studies. However, the literature is genuinely mixed: a well-controlled study found that the MGF peptide had no apparent effect on myoblasts or primary muscle stem cells even at high concentrations, and reviews have questioned whether the proposed peptide is meaningfully produced in the body at all.
Key studies
Each summary explains the design, what was found, and what it doesn't prove.
In rats, muscle damage caused a quick burst of the MGF form of IGF-1 that lined up with muscle stem cells switching on — supporting the idea that natural MGF is an early repair signal, though this says nothing about injecting MGF in people.
In a lab dish, the MGF peptide helped human muscle stem cells become more active and better at fusing, especially cells from younger people — a hint of potential, but not evidence that it works or is safe in actual patients.
When tested carefully, the MGF peptide did nothing measurable to muscle cells in the dish — a key counterweight showing the muscle-building claims for MGF are far from proven.
Experts reviewing the field argued there isn't solid proof the body actually makes a working MGF peptide, even though synthetic versions sometimes do things in a dish — a sober reminder the basic biology is contested.
A review that takes MGF's repair potential seriously but stresses how much is still unknown about how it works — and warns about people using it in sport before the science is in.
History
MGF was characterized largely through the work of Geoffrey Goldspink and colleagues in the late 1990s and 2000s, who described a mechanically-sensitive splice variant of IGF-1 produced in loaded or damaged muscle and coined the term 'Mechano Growth Factor.' Interest grew around its proposed role in satellite-cell activation and muscle hypertrophy, which led to its appearance as a gray-market injectable research peptide ('MGF' and longer-acting 'PEG-MGF') marketed to athletes and bodybuilders. The underlying biology remains contested, with subsequent studies both supporting and failing to replicate the peptide's reported effects.
PeptidePedia is for educational and informational purposes only. We do not sell peptides, prescribe peptides, provide medical advice, or recommend treatment. Peptides may not be approved for human use except in specific legal prescription or clinical contexts. Always consult a licensed medical professional before making health decisions.
Related peptides
A synthetic fragment of thymosin beta-4 studied in animals for wound healing, cardiac repair, and tissue regeneration.
A 15-amino-acid fragment derived from a stomach-protecting protein, widely studied in rodents for gut, tendon, and ligament repair.
A long-acting GHRH analog studied as a research peptide for sustained growth hormone elevation.